Although some studies reported that there was no significant difference in the ratio of RANKL/OPG between CN patients and participants without CN (Connors et al., 2018), in vitro and in vivo results have proposed the importance of this system in the development of CN (Geusens et al., 2006). The gene discussed is TNFRSF11B; the disease is cyclic hematopoiesis.